APG Asset Management US’s Vertex Pharmaceuticals VRTX Stock Holding History

APG Asset Management US’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,334	Closed	-$2.16M	–	177
2025 Q3	$2.16M	Hold	5,334	–	–	0.02%	100
2025 Q2	$2.41M	Hold	5,334	–	–	0.02%	92
2025 Q1	$2.59M	Hold	5,334	–	–	0.02%	95
2024 Q4	$2.15M	Sell	5,334 -666	-11%	-$309K	0.02%	96
2024 Q3	$2.82M	Sell	6,000 -70,048	-92%	-$33.6M	0.02%	85
2024 Q2	$35.8M	Buy	76,048 +1,676	+2%	+$727K	0.21%	61
2024 Q1	$31.3M	Buy	74,372 +23,967	+48%	+$10.1M	0.18%	66
2023 Q4	$20.5M	Buy	+50,405	New	+$18.6M	0.13%	67

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

APG Asset Management US's VRTX Position: Q4 2025 in Review

APG Asset Management US sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 5,334 shares — an estimated $2.16M sold.

APG Asset Management US first reported a position in VRTX in Q4 2023 and held it in 8 quarters. The position peaked at $35.8M in Q2 2024. 1,674 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

APG Asset Management US reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
APG Asset Management US sold 5,334 Vertex Pharmaceuticals shares in Q4 2025, an estimated $2.16M.
APG Asset Management US first reported a position in Vertex Pharmaceuticals in Q4 2023 and held it in 8 quarters.
APG Asset Management US's Vertex Pharmaceuticals position peaked at $35.8M in Q2 2024.
1,674 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.